Diabetes, but not pre-diabetes, is associated with shorter time to second-line therapy and worse outcomes in patients with multiple myeloma

Irit Avivi, Naama Yekutiel, Inbar Cohen*, Yael C. Cohen, Gabriel Chodick, Clara Weil

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Diabetes, but not pre-diabetes, is associated with shorter time to second-line therapy and worse outcomes in patients with multiple myeloma'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology